Internet Explorer is no longer supported by Microsoft. To browse the NIHR site please use a modern, secure browser like Google Chrome, Mozilla Firefox, or Microsoft Edge.

News

Latest news

Filter results

Audience
Specialty

Latest news

NIHR welcomes UK approval of Valneva COVID-19 vaccine

Following rigorous clinical trials supported by the NIHR and thorough data analysis, the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised the Valneva COVID-19 vaccine for UK use.

  • Published: 14 April 2022
Novavax COVID-19 Vaccine Study News

NIHR welcomes UK approval of the Novavax COVID-19 vaccine

The Medicines and Healthcare products Regulatory Agency (MHRA) has today authorised Novavax’s COVID-19 vaccine for use in the UK. This follows rigorous clinical trials supported by NIHR and a thorough analysis of the data by experts at the MHRA

  • Published: 03 February 2022
Cov-Boost Fractional Dose Study Recruiting

COVID-19 vaccine lower booster dose study launches across UK

Young adults have a stronger immune response to vaccines than older adults, and results from COVID-19 vaccine studies have suggested lower doses of the Pfizer or Moderna COVID-19 vaccines may give as good an immune response in young adults as higher doses.

  • Published: 18 January 2022